Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database - Université de Bretagne Occidentale
Journal Articles Thrombosis Research Year : 2016

Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database

Domains

Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system

Ghislaine Calvez  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-02044161

Submitted on : Thursday, February 21, 2019-12:30:43 PM

Last modification on : Thursday, April 18, 2024-4:26:16 PM

No file

Dates and versions

hal-02044161 , version 1 (21-02-2019)

Identifiers

  • HAL Id : hal-02044161 , version 1

Cite

Albert Trinh-Duc, Agnès Lillo-Le Louët, Éric Tellier, Thibault Viard, Grégoire Le Gal, et al.. Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database. Thrombosis Research, 2016, 146 (9), pp.43-45. ⟨hal-02044161⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST GETBO USPC IBSAM UP-SANTE
24 View
0 Download

Share

More